Biogen, Edinburgh University partner for neurodegenerative disease research

English: Self-created from an MRI scan of my o...

Biogen Idec is funding a three-year collaboration with the University of Edinburgh in Scotland to explore the cell processes behind multiple sclerosis and motor neurone disease.

The partnership, which combines the University’s expertise in translational medicine with Biogen Idec’s strengths in drug discovery and development, will include identifying drug compounds that could potentially be used as treatments for the neurodegenerative conditions.

It will involve clinicians and scientists, based at the Edinburgh BioQuarter, site of the University’s MRC Centre for Regenerative Medicine, and will draw on the University of Edinburgh’s capabilities in neuroscience, stem cell research and regeneration.

In-depth portrait

Ken Rhodes, Biogen Idec’s vice president of neurology research, said the collaboration was expected to “provide an in-depth portrait” of the pathophysiology of multiple sclerosis and motor neurone disease, while identifying “important new targets for potential therapies”.

The company has a historical association with the University of Edinburgh. One of its founders, the molecular biologist Sir Kenneth Murray, worked at the University, where he used his expertise in genetic engineering to develop a vaccine against hepatitis B.

Enhanced by Zemanta

Responder

Por favor, inicia sesión con uno de estos métodos para publicar tu comentario:

Logo de WordPress.com

Estás comentando usando tu cuenta de WordPress.com. Cerrar sesión / Cambiar )

Imagen de Twitter

Estás comentando usando tu cuenta de Twitter. Cerrar sesión / Cambiar )

Foto de Facebook

Estás comentando usando tu cuenta de Facebook. Cerrar sesión / Cambiar )

Google+ photo

Estás comentando usando tu cuenta de Google+. Cerrar sesión / Cambiar )

Conectando a %s